Helge Alfred Reisch

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Rhodes Technologies. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helge Alfred Reisch. Retrieved from https://idiyas.com/inventor/helge-alfred-reisch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 39(Granted Patents)

Company Filing History:

15 out of 47

Rhodes Technologies

patents

Years Active: 2014-2020

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10874662 - Acetate salt of buprenorphine and methods for preparing buprenorphine (2020-12-29),

2. 10835528 - Acetate salt of buprenorphine and methods for preparing buprenorphine (2020-11-17),

3. 10406152 - Acetate salt of buprenorphine and methods for preparing buprenorphine (2019-09-10),

4. 10278967 - Acetate salt of buprenorphine and methods for preparing buprenorphine (2019-05-07),

5. 9926329 - Acetate salt of buprenorphine and methods for preparing buprenorphine (2018-03-27),

6. 9834562 - 7 beta-substituted 6a, 14a-ethenomorphinans and 7beta-substituted 6a, 14a-ethanomorphinans (2017-12-05),

7. 9657030 - Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof (2017-05-23),

8. 9624232 - Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof (2017-04-18),

9. 9593124 - Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof (2017-03-14),

10. 9499557 - Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof (2016-11-22),

11. 9475770 - Low-temperature synthesis of methylphenidate hydrochloride (2016-10-25),

12. 9315514 - 1,3-dioxanomorphides and 1,3-dioxanocodides (2016-04-19),

13. 9309258 - Process for N-dealkylation of tertiary amines (2016-04-12),

14. 9127014 - Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof (2015-09-08),

15. 8921556 - Process for N-dealkylation of tertiary amines (2014-12-30),

Title: Helge Alfred Reisch - Innovator in Pharmaceutical Patents

Introduction

Helge Alfred Reisch is an accomplished inventor based in Westerly, RI, USA, renowned for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 15 patents, Reisch has established himself as a key figure in the field of drug development and formulations. His work primarily focuses on the synthesis and application of pharmaceutical compounds, particularly buprenorphine.

Latest Patents

Among his latest innovations, Reisch has developed patents for the acetate salt of buprenorphine and methods for preparing buprenorphine. These patents provide a comprehensive disclosure of the acetate salts of buprenorphine, including its anhydrates, solvates, hydrates, and various crystalline forms. A notable aspect of these innovations is that the acetate salts are essentially free of impurities. Furthermore, the disclosures detail methods for preparing the acetate salts, the buprenorphine free base derived from these salts, other salts, and ultimately pharmaceutical compositions that maintain high purity standards.

Career Highlights

Helge Alfred Reisch's career is marked by his role at Rhodes Technologies, where he applies his expertise to advance pharmaceutical research and development. His work has not only expanded the scientific community's understanding of buprenorphine but has also contributed to the improvement of therapeutic applications.

Collaborations

Reisch has had the opportunity to collaborate with esteemed colleagues such as Joshua Robert Giguere and Sergio Sandoval. Their joint efforts have fostered a creative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

In conclusion, Helge Alfred Reisch is a noteworthy inventor whose contributions to the field of pharmaceuticals have had a significant impact. His innovative patents on buprenorphine enhance the quality and efficacy of medical treatments, showcasing his dedication to improving health care through meaningful advancements in drug formulation.

Profile summary based on public USPTO records.